Ricardo H Alvarez

Ricardo H Alvarez

UNVERIFIED PROFILE

Are you Ricardo H Alvarez?   Register this Author

Register author
Ricardo H Alvarez

Ricardo H Alvarez

Publications by authors named "Ricardo H Alvarez"

Are you Ricardo H Alvarez?   Register this Author

51Publications

1154Reads

49Profile Views

Elevated serum levels of sialyl Lewis X (sLe) and inflammatory mediators in patients with breast cancer.

Breast Cancer Res Treat 2019 Aug 3;176(3):545-556. Epub 2019 May 3.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05258-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653624PMC
August 2019

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.

Ther Adv Med Oncol 2019 14;11:1758835919866065. Epub 2019 Aug 14.

Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919866065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696837PMC
August 2019

Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.

Hum Pathol 2018 07 22;77:121-129. Epub 2018 Apr 22.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.04.002DOI Listing
July 2018

Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer.

Oncologist 2018 06 27;23(6):660-669. Epub 2018 Feb 27.

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067931PMC
June 2018

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Cancer 2018 06 26;124(11):2299-2305. Epub 2018 Mar 26.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31336DOI Listing
June 2018

Identification of frequent somatic mutations in inflammatory breast cancer.

Breast Cancer Res Treat 2017 Jun 27;163(2):263-272. Epub 2017 Feb 27.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4165-0DOI Listing
June 2017

Cancer pain: a review of epidemiology, clinical quality and value impact.

Future Oncol 2017 Apr 23;13(9):833-841. Epub 2016 Nov 23.

Cancer Treatment Centers of America, Newnan, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0423DOI Listing
April 2017

Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'.

Oncology 2016 6;91(6):299-301. Epub 2016 Oct 6.

Cancer Treatment Center of America in Philadelphia, Pa., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000450682DOI Listing
January 2017

High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.

Oncologist 2016 Jan 9;21(1):21-7. Epub 2015 Dec 9.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709200PMC
January 2016

Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.

Thromb Haemost 2015 Mar 6;113(3):593-8. Epub 2014 Nov 6.

Dr. J. M. Reuben, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA, Tel.: +1 713 745 6837, Fax: +1 713 794 1838, E-mail:

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1160/TH14-07-0597
Publisher Site
http://dx.doi.org/10.1160/TH14-07-0597DOI Listing
March 2015

High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.

PLoS One 2014 8;9(1):e83113. Epub 2014 Jan 8.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083113PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885405PMC
September 2014

Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.

Springerplus 2014 31;3:166. Epub 2014 Mar 31.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA ; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX USA ; Department of Radiation Oncology-Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1186%2F2193-1801-3-1
Web Search
http://springerplus.springeropen.com/articles/10.1186/2193-1
Publisher Site
http://dx.doi.org/10.1186/2193-1801-3-166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977020PMC
April 2014

Locoregional interaction of ixabepilone (ixempra) after breast cancer radiation.

Oncologist 2013 12;18(3):265-70. Epub 2013 Feb 12.

Department of Radiation Oncology, The University of TexasMDAnderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607521PMC
September 2013

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer.

Breast Cancer 2013 Apr 3;20(2):103-10. Epub 2013 Feb 3.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1155 Herman P Pressler CPB5.3450, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0446-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123423PMC
April 2013

Inflammatory breast cancer: what we know and what we need to learn.

Oncologist 2012 14;17(7):891-9. Epub 2012 May 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399643PMC
February 2013

Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.

Int J Radiat Oncol Biol Phys 2012 Aug 26;83(5):1381-6. Epub 2012 Jan 26.

Department of Radiation Oncology, The Morgan Welch Inflammatory Breast Cancer Clinic, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.10.040DOI Listing
August 2012

Metastasis in the breast mimicking inflammatory breast cancer.

J Clin Oncol 2012 Aug 25;30(22):e202-6. Epub 2012 Jun 25.

The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, 1155 Herman P. Pressler, CPB5.3458, Houston, TX 77030-3721, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.2230DOI Listing
August 2012

Novel targeted agents for the treatment of advanced breast cancer.

Future Med Chem 2012 May;4(7):893-914

Fundaleu, Fundación para Combatir la Leucemia, Angélica Ocampo, Servicio de Oncología Clínica, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://www.future-science.com/doi/10.4155/fmc.12.45
Publisher Site
http://dx.doi.org/10.4155/fmc.12.45DOI Listing
May 2012

Bevacizumab treatment for advanced breast cancer.

Oncologist 2011 5;16(12):1684-97. Epub 2011 Oct 5.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248767PMC
April 2012

Ixabepilone for the treatment of breast cancer.

Ann Med 2011 17;43(6):477-86. Epub 2011 May 17.

Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07853890.2011.579151DOI Listing
January 2012

Present and future evolution of advanced breast cancer therapy.

Breast Cancer Res 2010 22;12 Suppl 2:S1. Epub 2010 Oct 22.

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1155 Herman P, Pressler, CPB5.3458, Houston, TX 77030-3721, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972555PMC
January 2011

Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.

Breast Cancer Res Treat 2010 Dec 16;124(3):701-5. Epub 2010 Oct 16.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1212-5DOI Listing
December 2010

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

J Clin Oncol 2010 Oct 30;28(28):4316-23. Epub 2010 Aug 30.

Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.2419DOI Listing
October 2010

Emerging targeted therapies for breast cancer.

J Clin Oncol 2010 Jul 7;28(20):3366-79. Epub 2010 Jun 7.

The University of Texas M D Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX 77030-3721, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.4011DOI Listing
July 2010

Biomarkers for breast cancer: the search continues.

Cancer Biol Ther 2010 Jan 10;9(1):31-2. Epub 2010 Jan 10.

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.9.1.10917DOI Listing
January 2010

The biology of chronic myelogenous leukemia: implications for imatinib therapy.

Semin Hematol 2007 Jan;44(1 Suppl 1):S4-14

Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2006.12.007DOI Listing
January 2007

The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.

Cancer 2006 Oct;107(8):1918-29

Department of Internal Medicine, The University of Texas School of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22215DOI Listing
October 2006

Biology of platelet-derived growth factor and its involvement in disease.

Mayo Clin Proc 2006 Sep;81(9):1241-57

Department of Internal Medicine, The University of Texas at Houston Medical School, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/81.9.1241DOI Listing
September 2006

Investigational strategies in chronic myelogenous leukemia.

Hematol Oncol Clin North Am 2004 Jun;18(3):619-39, ix

Department of Leukemia, University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2004.03.004DOI Listing
June 2004